Search research articles
Contact Us
Filters
Showing results (161-170 of 189) with videos related to
Page
of 19
Sort By:
The Journal of Investigative Dermatology
|
February 13, 2021
Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis
Elisabeth Aberer, Wolfgang R Sperr, Agnes Bretterklieber, et al.
Journal of Clinical Immunology
|
February 16, 2024
Post-transplant Inflammatory Bowel Disease Associated with Donor-Derived TIM-3 Deficiency
Adrian Baldrich, Dominic Althaus, Thomas Menter, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 20, 2022
Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium
Polina Pyatilova, Cem Akin, Iván Alvarez-Twose, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 12, 2023
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT
Peter Valent, Gregor Hoermann, Patrizia Bonadonna, et al.
Allergy
|
February 13, 2022
AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position Paper
Christoph Bergmann, Aurélie Poli, Ioana Agache, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 27, 2022
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium
Peter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 20, 2022
Proposed European Competence Network on Mastocytosis-American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis
Jason Gotlib, Juliana Schwaab, William Shomali, et al.
Journal of the American Academy of Dermatology
|
February 14, 2026
Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER study
Frank Siebenhaar, Sigurd Broesby-Olsen, Mariana Castells, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
April 8, 2021
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
Patrizia Bonadonna, Knut Brockow, Marek Niedoszytko, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 24, 2021
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
Theo Gülen, Cem Akin, Patrizia Bonadonna, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 189) with videos related to
Sort By:
Page
of 19
The Journal of Investigative Dermatology
|
February 13, 2021
Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis
Elisabeth Aberer, Wolfgang R Sperr, Agnes Bretterklieber, et al.
Journal of Clinical Immunology
|
February 16, 2024
Post-transplant Inflammatory Bowel Disease Associated with Donor-Derived TIM-3 Deficiency
Adrian Baldrich, Dominic Althaus, Thomas Menter, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 20, 2022
Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium
Polina Pyatilova, Cem Akin, Iván Alvarez-Twose, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 12, 2023
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT
Peter Valent, Gregor Hoermann, Patrizia Bonadonna, et al.
Allergy
|
February 13, 2022
AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position Paper
Christoph Bergmann, Aurélie Poli, Ioana Agache, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 27, 2022
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium
Peter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 20, 2022
Proposed European Competence Network on Mastocytosis-American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis
Jason Gotlib, Juliana Schwaab, William Shomali, et al.
Journal of the American Academy of Dermatology
|
February 14, 2026
Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER study
Frank Siebenhaar, Sigurd Broesby-Olsen, Mariana Castells, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
April 8, 2021
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
Patrizia Bonadonna, Knut Brockow, Marek Niedoszytko, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 24, 2021
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
Theo Gülen, Cem Akin, Patrizia Bonadonna, et al.
Page
of 19